Tapewire

NYSE · USD

MOH

MOLINA HEALTHCARE, INC.

Export transactions ↓
Tapewire entity
3504
SEC CIK
0001179929
Parsed reports
704

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202610
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2024 Filed Feb 16, 2024 21:48 UTC SaleCommon Stock 750 $399.12 $299,340.00
Disclosure

SEC source: 0001179929-24-000043 · wk-form4_1708120080.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,701

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date (200 shares sold at $399.45 per share and 550 shares sold at $399.00 per share).

F2 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 21:46 UTC
WOLF DALE BDirector
SaleCommon Stock 1,500 $398.38 $597,570.00
Disclosure

SEC source: 0001179929-24-000042 · wk-form4_1708120005.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,867

F1 · price: Represents the selling price per share of all 1,500 shares.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:45 UTC
Bacon DebraEVP, Medicaid
SaleCommon Stock 500 $396.22 $198,110.00
Disclosure

SEC source: 0001179929-24-000041 · wk-form4_1708119937.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,573

F1 · price: Represents the selling price per share of all 500 shares.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 2,116 $383.82 $812,165.24
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 6

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,531

F6 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F7 · balance_after: Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 1,815 $384.58 $698,009.07
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 5

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,647

F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 1,203 $385.80 $464,111.39
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 4

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,462

F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 4,351 $387.00 $1,683,837.00
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 3

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,665

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 4,251 $387.94 $1,649,124.44
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 2

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,016

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:38 UTC
Keim Mark LowellChief Financial Officer
SaleCommon Stock 1,264 $388.61 $491,208.10
Disclosure

SEC source: 0001179929-24-000037 · wk-form4_1707946664.xml · nonDerivative · entry 1

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,267

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:35 UTC SaleCommon Stock 120 $384.54 $46,144.80
Disclosure

SEC source: 0001179929-24-000036 · wk-form4_1707946501.xml · nonDerivative · entry 2

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,207

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.41 to $384.63. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:35 UTC SaleCommon Stock 591 $383.97 $226,923.32
Disclosure

SEC source: 0001179929-24-000036 · wk-form4_1707946501.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,327

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.365 to $384.360. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:17 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000017 · wk-form4_1704241059.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,552

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:25 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000024 · wk-form4_1704241512.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,323

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:24 UTC
WOLF DALE BDirector
GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000023 · wk-form4_1704241446.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,367

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:23 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000022 · wk-form4_1704241387.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,918

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:22 UTC
ROMNEY RONNADirector
GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000021 · wk-form4_1704241339.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,059

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:21 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000020 · wk-form4_1704241278.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 19,451

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:20 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000019 · wk-form4_1704241217.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,118

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 00:19 UTC GrantCommon Stock 152 $361.31 $54,919.12
Disclosure

SEC source: 0001179929-24-000018 · wk-form4_1704241131.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,653

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
November 29, 2023 Filed Nov 30, 2023 00:44 UTC
ROMNEY RONNADirector
SaleCommon Stock 335 $358.00 $119,929.00
Disclosure

SEC source: 0001179929-23-000139 · wk-form4_1701305068.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 16,907

F1 · price: Represents the actual selling price per share of all 335 shares.

F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
November 21, 2023 Filed Nov 25, 2023 00:40 UTC
Zubretsky Joseph MDirector · President & CEO
GiftCommon Stock 5,700 $0.00 $0.00
Disclosure

SEC source: 0001179929-23-000137 · wk-form4_1700872822.xml · nonDerivative · entry 1

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,816

F1 · kind: Reflects the gift of common stock to a charitable donor advised fund.

F2 · price: Price not applicable to gift.

F3 · balance_after: 22,960 shares vest on March 1, 2024; 13,960 shares vest on March 1, 2025; and 7,548shares vest on March 1, 2026. The remainder of the shares are vested.

Read SEC document
October 30, 2023 Filed Oct 31, 2023 22:48 UTC SaleCommon Stock 1,134 $325.96 $369,638.64
Disclosure

SEC source: 0001179929-23-000134 · wk-form4_1698792480.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 19,299

F1 · price: Represents the selling price per share of all 1,134 shares.

F2 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:26 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000119 · wk-form4_1696289188.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,400

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:32 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000126 · wk-form4_1696289555.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,171

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:31 UTC
WOLF DALE BDirector
GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000125 · wk-form4_1696289499.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,215

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:30 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000124 · wk-form4_1696289444.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,766

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:30 UTC
ROMNEY RONNADirector
GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000123 · wk-form4_1696289397.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,242

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:29 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000122 · wk-form4_1696289355.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 20,433

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:27 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000120 · wk-form4_1696289238.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,501

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

Read SEC document
October 01, 2023 Filed Oct 2, 2023 23:28 UTC GrantCommon Stock 168 $327.89 $55,085.52
Disclosure

SEC source: 0001179929-23-000121 · wk-form4_1696289290.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,966

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023.

Read SEC document
September 13, 2023 Filed Sep 13, 2023 23:55 UTC
HEBERT MAURICEChief Accounting Officer
SaleCommon Stock 692 $328.15 $227,079.80
Disclosure

SEC source: 0001179929-23-000110 · wk-form4_1694649306.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,528

F1 · price: Represents the selling price per share of all 692 shares.

F2 · balance_after: Shares shall vest as follows: 4,109 shares on March 1, 2024; 2,757 shares on March 1, 2025; and 1,582 shares on March 1, 2026. The remainder of the shares are vested.

Read SEC document
August 07, 2023 Filed Aug 8, 2023 00:21 UTC
Russo MarcEVP, Health Plans
SaleCommon Stock 2,523 $312.72 $788,992.56
Disclosure

SEC source: 0001179929-23-000106 · wk-form4_1691454097.xml · nonDerivative · entry 1

Russo Marc · CIK 0001504606 · EVP, Health Plans

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,093

F1 · price: Represents the actual selling price per share of all 2,523 shares.

F2 · balance_after: Shares shall vest as follows: 4,109 shares on March 1, 2024; 2,757 shares on March 1, 2025; and 1,582 shares on March 1, 2026. The remainder of the shares are vested.

Read SEC document
August 04, 2023 Filed Aug 4, 2023 23:40 UTC SaleCommon Stock 723 $301.25 $217,803.75
Disclosure

SEC source: 0001179929-23-000104 · wk-form4_1691192446.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 20,265

F1 · price: Represents the actual selling price per share of all 723 shares.

F2 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 22:49 UTC
Barlow Jeff D.Chief Legal Officer
SaleCommon Stock 5,767 $303.01 $1,747,430.41
Disclosure

SEC source: 0001179929-23-000102 · wk-form4_1691102977.xml · nonDerivative · entry 2

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,973

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $302.89 to $303.26. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F3 · balance_after: Shares shall vest as follows: 4,437 shares on March 1, 2024; 2,936 shares on March 1, 2025; and 1,761 shares on March 1, 2026. The remaining shares are vested.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 22:49 UTC
Barlow Jeff D.Chief Legal Officer
SaleCommon Stock 6,733 $302.57 $2,037,187.65
Disclosure

SEC source: 0001179929-23-000102 · wk-form4_1691102977.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,740

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $301.89 to $302.88. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
July 31, 2023 Filed Aug 1, 2023 22:59 UTC SaleCommon Stock 1,500 $303.89 $455,834.55
Disclosure

SEC source: 0001179929-23-000100 · wk-form4_1690930743.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,232

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date. Actual prices ranged from $303.795 to $304.04. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 21:01 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000090 · wk-form4_1688418108.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,732

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 21:00 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000089 · wk-form4_1688418019.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,333

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:59 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000088 · wk-form4_1688417968.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,798

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:58 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000087 · wk-form4_1688417908.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 20,988

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:57 UTC
ROMNEY RONNADirector
GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000086 · wk-form4_1688417849.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,074

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:56 UTC
WOLF DALE BDirector
GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000085 · wk-form4_1688417754.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,047

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:54 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000084 · wk-form4_1688417688.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,598

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 3, 2023 20:53 UTC GrantCommon Stock 183 $301.24 $55,126.92
Disclosure

SEC source: 0001179929-23-000083 · wk-form4_1688417610.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,003

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:04 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 75 $301.24 $22,593.00
Disclosure

SEC source: 0001179929-23-000092 · wk-form4_1688418281.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,473

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: Represents the closing price of Issuer's common stock on June 30, 2023. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2023, the first day of the ESPP offering period, and (2) June 30, 2023, the last day of the ESPP offering period.

F3 · balance_after: Shares shall vest as follows: 4,437 shares on March 1, 2024; 2,936 shares on March 1, 2025; and 1,761 shares on March 1, 2026. The remaining shares are vested.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:03 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 75 $301.24 $22,593.00
Disclosure

SEC source: 0001179929-23-000091 · wk-form4_1688418226.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,429

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: Represents the closing price of Issuer's common stock on June 30, 2023. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2023, the first day of the ESPP offering period, and (2) June 30, 2023, the last day of the ESPP offering period.

F3 · balance_after: Shares shall vest as follow: 4,594 shares on March 1, 2024; 3,093 shares on March 1, 2025, and 1,704 shares on March 1, 2026. Such shares include the 5,113 shares granted on March 1, 2023 and previously reported, which are subject to vesting in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. The remaining shares are vested.

Read SEC document
April 01, 2023 Filed Apr 3, 2023 22:50 UTC GrantCommon Stock 206 $267.49 $55,102.94
Disclosure

SEC source: 0001179929-23-000062 · wf-form4_168056222563318.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,549

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023.

Read SEC document
April 01, 2023 Filed Apr 3, 2023 22:50 UTC GrantCommon Stock 206 $267.49 $55,102.94
Disclosure

SEC source: 0001179929-23-000063 · wf-form4_168056224174048.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,615

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023.

Read SEC document
April 01, 2023 Filed Apr 3, 2023 22:50 UTC GrantCommon Stock 206 $267.49 $55,102.94
Disclosure

SEC source: 0001179929-23-000061 · wf-form4_168056221064496.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,415

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023.

Read SEC document
April 01, 2023 Filed Apr 3, 2023 22:50 UTC
WOLF DALE BDirector
GrantCommon Stock 206 $267.49 $55,102.94
Disclosure

SEC source: 0001179929-23-000060 · wf-form4_168056219613150.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,864

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.